Cohort Company News

Matthew Segar, MD, of The Texas Heart Institute, discusses new research evaluating whether AI‑enabled ECG analysis can detect aortic stenosis years before traditional symptom‑driven diagnosis.... Read More →

First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division IRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Toro Neurovascular today... Read More →

Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital, and ROM Utrecht invest alongside existing investors Invest-NL, EIC Fund, Fred Moll,... Read More →

New investor Nexpring Health™ joins existing investors, including Sofinnova, Bpifrance, and Trill Impact MENLO PARK, Calif.–(BUSINESS WIRE)–May Health, a medical device company dedicated to helping... Read More →

The landscape of preclinical neuroscience research is shifting. Growing ethical considerations, cost pressures, and translational limitations have accelerated interest in organoid alternatives to animal models... Read More →

In this episode, Armor Medical Co-founder and CEO Kelsey Mayo shares her ultimate entrepreneurial journey. Mayo recognized early on that her career needed to make... Read More →

REDWOOD CITY, Calif., Feb. 25, 2026 /PRNewswire/ — Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the closing of $10.7M... Read More →

Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, today announced it has received a second 510(k) clearance... Read More →

Juan C. Jimenez addresses the heart care crisis in the United States where half of all counties have no specialist to read heart scans. There... Read More →

SALT LAKE CITY, Feb. 24, 2026 /PRNewswire/ — Xenocor, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the new Xenocor... Read More →

This report presents an illustrative case demonstrating a practical collaborative workflow that integrates CLE with on-site neuropathologist consultation for real-time margin assessment during glioma resection.... Read More →

Abstract Aptamers are single-stranded oligonucleotides that bind molecular targets with high affinity and specificity. However, their discovery remains time-consuming, expensive, and susceptible to experimental biases.... Read More →

Preliminary three-month results from the first five human implantations of StentIt’s resorbable fibrillated scaffold (RFS) reveal a technical success rate of 100% and no device-... Read More →

Motion-Preserving Lumbar Spine Surgery – Stabilization Without Fusion for Patients with Degenerative Spondylolisthesis San Carlos, CA — February 18, 2026 /OrthoSpineNews/ — The U.S. Food... Read More →

Background Extravascular implantable cardioverter-defibrillators (EV-ICDs) are being developed to overcome limitations of current implantable cardioverter-defibrillators (ICDs). The AtaCor parasternal EV-ICD system uses an extravascular lead... Read More →

Transaction will expand VB Spine’s enhanced visualization portfolio to include augmented reality navigation with the Augmedics xvision Spine System® NEW YORK & CHICAGO–(BUSINESS WIRE)–VB Spine... Read More →

WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 — Retia Medical today announced that the U.S. Food and Drug Administration (FDA) has granted... Read More →

GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ — InVera Medical, an Irish medical technology company, has received European regulatory approval for a new minimally invasive device... Read More →